SlideShare a Scribd company logo
HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
BIOMIMESYS®
is a registered trademark
of HCS Pharma
+33 769 999 137
www.biomimesys.com
hello@biomimesys.com
Innovative Hydroscaffolds™ for 3D Cell Culture to better mimic the tissue microenvironment and
provide more predictive tools for drug development and metabolic studies
Other BIOMIMESYS® products available
PRODUCT
BIOMIMESYS® Oncology is a new generation of
mimetic Hydroscaffolds™ for 3D cell culture. Available in
a ready-to-use format, it enables the culture of cells
under physiological conditions that are representative of
the microenvironment found in whole tissues. The highly
porous structure of BIOMIMESYS® allows cells to diffuse
into the 3D matrix, where they can fix and begin to
develop. The structure and conformation of cells cultured
in BIOMIMESYS®, such as cancer cells that
spontaneously form spheroids, strongly resemble the
structures formed in vivo. Also, the functionality of the
BIOMIMESYS® matrix is proved by the expression of
genes and proteins at levels that are again more similar
to those found in vivo. Cells cultured in BIOMIMESYS® give results that are more physiological than
those grown in 2D culture and are closer to those obtained in vivo.
Figure 1: SEM picture
HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
BIOMIMESYS®
is a registered trademark
of HCS Pharma
+33 769 999 137
www.biomimesys.com
hello@biomimesys.com
Hyaluronic acid (HA) being a major component of the cell’s extracellular matrix (ECM), BIOMIMESYS®
Hydroscaffolds™ for 3D cell culture is an ideal study model because it is:
 Highly porous for the simple extraction of RNA and proteins
 Biodegradable for easy cell retrieval
 Transparent for direct visualization of cells
 Representative of the cell microenvironment in terms of cell-cell interactions, cell-matrix
interactions and the expression of proteins and genes
 BIOMIMESYS® Oncology is made of HYALURONIC ACID (HA), a glycosaminoglycan. Hyaluronic acid is a major
component of the extracellular matrix (ECM), and it plays an IMPORTANT ROLE in connective tissue.
 The HA-based Hydroscaffolds™ are formed by crosslinking HA and type I collagen with ADH to form
reticulated chains.
 High molecular weight Hyaluronic acid + type I collagen.
 BIODEGRADABLE product.
 PHYSICOCHEMICAL FEATURES
o Porosity: 150-200um
o Rheology: Young’s modulus: E= 1 kPa +/-Swelling ratio = 75 ± 10g/g
READY-TO-USE
BIOMIMESYS®
Hydroscaffolds™ technology is EASY to handle handling & READY-TO-USE. Upon receiving
the vacuum sealed 96-well plate open it (under a hood) and add the cells directly on top of the matrix.
Changing the culture medium is easy as well. To remove medium, simply draw the medium with a
pipette between the matrix and the edge of the well. To refresh the medium, place fresh medium onto
the surface of the matrix.
96-well plate format
10-40µl of cell
suspension
dropped on the
surface of
BIOMIMESYS®
Culture medium
is gently added
on the side of
the well to
obtain qs. 200µl
HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
BIOMIMESYS®
is a registered trademark
of HCS Pharma
+33 769 999 137
www.biomimesys.com
hello@biomimesys.com
COMPATIBLE TECHNOLOGIES
BIOMIMESYS® Hydroscaffolds™ has many properties (translucent, porous, and biodegradable) that
make it ideal for use with numerous downstream applications. The growing cells are easily retrieved
from the matrix by a gentle and rapid procedure, this means that cells cultured in BIOMIMESYS® may
be analyzed using all technologies as shown below.
TRANSPARENT POROUS BIODEGRADABLE SOLID
Microscopy PCRs Flow cytometry Histology
Plate Reader (OD,
fluorescence,
luminescence
Western-Blot
ELISA
SUCESSFULLY TESTED CELLS
Cancer Cells Lines & Primary Tumors
Human brain metastasis SA87
Human breast adenocarcinoma MCF-7
Human breast carcinoma CAL-51
Human cervix adenocarcinoma HeLa
Human colorectal adenocarcinoma DLD-1, HT29, Caco-2
Human glioblastoma CB109 / CB74 / CB191
Human liver hepatocellular carcinoma HepG2
Human liver hepatoma PLC / PRF-5
Human lung carcinoma NCI-H460
Human osteosarcoma SaOs
Human ovarian carcinoma IGROV-1
Human pancreas carcinoma PANC-1
Human prostate cancer PC3
RELATED PUBLICATIONS
 “DIRECT EFFECT OF BEVACIZUMAB ON GLIOBLASTOMA CELL LINES IN VITRO“. SIMON T., COQUEREL B., ET
AL. (2014) NEUROMOLECULAR MED.; 16(4):752-71
 “SURVIVAL OF CORD BLOOD HAEMATOPOIETIC STEM CELLS IN A HYALURONAN HYDROGEL FOR EX VIVO
BIOMIMICRY”. DEMANGE E., KASSIM Y., ET AL. (2012) J TISSUE ENG REGEN MED 7(11):901-10
 “ELASTIN-DERIVED PEPTIDES: MATRIKINES CRITICAL FOR GLIOBLASTOMA CELL AGGRESSIVENESS IN A 3-D
SYSTEM”. COQUEREL B., POYER F., ET AL. (2009). GLIA 57(16): 1716-26.
 “COLLAGENS, STROMAL CELL-DERIVED FACTOR-1ALPHA AND BASIC FIBROBLAST GROWTH FACTOR
INCREASE CANCER CELL INVASIVENESS IN A HYALURONAN HYDROGEL”. DAVID L., DULONG V., ET AL. (2008).
CELL PROLIF 41(2): 348-64
HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
BIOMIMESYS®
is a registered trademark
of HCS Pharma
+33 769 999 137
www.biomimesys.com
hello@biomimesys.com
 “HYALURONAN HYDROGEL: AN APPROPRIATE THREE-DIMENSIONAL MODEL FOR EVALUATION OF
ANTICANCER DRUG SENSITIVITY.” DAVID L., DULONG V., ET AL. (2008). ACTA BIOMATER 4(2): 256-63
 “RETICULATED HYALURONAN HYDROGELS: A MODEL FOR EXAMINING CANCER CELL INVASION IN 3D.”
DAVID L., DULONG V., ET AL. (2004). MATRIX BIOL 23(3): 183-93
PRICING
BIOMIMESYS® hydroscaffold is sold for RESEARCH USE ONLY.
96-WELL PLATE
**price per plate**
Quantity of 96-well plates 1 ≥ 10 ≥ 100 ≥ 1000
BIO_ONC_96_96_transp
(96 well plate with 96 Hydroscaffolds™)
BIO_ONC_96_24_transp
(96 well plate with 24 Hydroscaffolds™)
Quantity of 96-well *BLACK* plates 1 ≥ 10 ≥ 100 ≥ 1000
BIO_ONC_96_96_black
(96 well plate with 96 Hydroscaffolds™)
BIO_ONC_96_24_black
(96 well plate with 24 Hydroscaffolds™)
BIO_ONC_384_384_black
(384 well plate with 384 Hydroscaffolds™)
Contact Information
HCS Pharma
hello@biomimesys.com
http://www.biomimesys.com

More Related Content

What's hot

Virta seminar
Virta seminarVirta seminar
Virta seminar
virta wagde
 
Leukocyte extravasation
Leukocyte extravasationLeukocyte extravasation
Leukocyte extravasation
devadevi666
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
HCS Pharma
 
Transplantation journal
Transplantation journalTransplantation journal
Transplantation journal
Scidoc Publishers
 
Journal of stem cells research
Journal of stem cells researchJournal of stem cells research
Journal of stem cells research
Scidoc Publishers
 
Stem cells journal
Stem cells  journalStem cells  journal
Stem cells journal
Scidoc Publishers
 
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...Van-Tinh Nguyen
 
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and promoting hep...
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and  promoting hep...BIOMIMESYS® Liver, a 3D cell culture model for maintaining and  promoting hep...
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and promoting hep...
HCS Pharma
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
HCS Pharma
 
Inositol lipid signalling
Inositol lipid signallingInositol lipid signalling
Inositol lipid signalling
mds-web
 
Principles of cell culture
Principles of cell culturePrinciples of cell culture
Principles of cell cultureostadhosseini
 
Culture media
Culture media Culture media
Culture media
Ankita Singh
 
Presentation okkkk
Presentation okkkkPresentation okkkk
Presentation okkkk
FabehaNafees
 
Interventional orthopedics foundation amniotic tissue products poster
Interventional orthopedics foundation amniotic tissue products posterInterventional orthopedics foundation amniotic tissue products poster
Interventional orthopedics foundation amniotic tissue products poster
Chris Centeno
 
Blood
Blood Blood
Amniotic Stem Cell Products Testing Interventional Orthopedics Foundation
Amniotic Stem Cell Products Testing Interventional Orthopedics FoundationAmniotic Stem Cell Products Testing Interventional Orthopedics Foundation
Amniotic Stem Cell Products Testing Interventional Orthopedics Foundation
Chris Centeno
 

What's hot (19)

Virta seminar
Virta seminarVirta seminar
Virta seminar
 
Leukocyte extravasation
Leukocyte extravasationLeukocyte extravasation
Leukocyte extravasation
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
 
Transplantation journal
Transplantation journalTransplantation journal
Transplantation journal
 
Journal of stem cells research
Journal of stem cells researchJournal of stem cells research
Journal of stem cells research
 
Stem cells journal
Stem cells  journalStem cells  journal
Stem cells journal
 
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...
Inhibition mmp 2 and mmp-9 of different molecule weigh function by membrane s...
 
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and promoting hep...
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and  promoting hep...BIOMIMESYS® Liver, a 3D cell culture model for maintaining and  promoting hep...
BIOMIMESYS® Liver, a 3D cell culture model for maintaining and promoting hep...
 
Prabhakar Singh- IV_SEM-ANIMAL CELL CULTURE MEDIA
Prabhakar Singh- IV_SEM-ANIMAL CELL CULTURE MEDIAPrabhakar Singh- IV_SEM-ANIMAL CELL CULTURE MEDIA
Prabhakar Singh- IV_SEM-ANIMAL CELL CULTURE MEDIA
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
 
Inositol lipid signalling
Inositol lipid signallingInositol lipid signalling
Inositol lipid signalling
 
Principles of cell culture
Principles of cell culturePrinciples of cell culture
Principles of cell culture
 
Culture media
Culture media Culture media
Culture media
 
Polymeric Porous 3-D Scaffolds
Polymeric Porous 3-D ScaffoldsPolymeric Porous 3-D Scaffolds
Polymeric Porous 3-D Scaffolds
 
JL Poster
JL PosterJL Poster
JL Poster
 
Presentation okkkk
Presentation okkkkPresentation okkkk
Presentation okkkk
 
Interventional orthopedics foundation amniotic tissue products poster
Interventional orthopedics foundation amniotic tissue products posterInterventional orthopedics foundation amniotic tissue products poster
Interventional orthopedics foundation amniotic tissue products poster
 
Blood
Blood Blood
Blood
 
Amniotic Stem Cell Products Testing Interventional Orthopedics Foundation
Amniotic Stem Cell Products Testing Interventional Orthopedics FoundationAmniotic Stem Cell Products Testing Interventional Orthopedics Foundation
Amniotic Stem Cell Products Testing Interventional Orthopedics Foundation
 

Similar to BIOMIMESYS® Oncology

A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
HCS Pharma
 
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
ComprehensiveBiologi
 
2012 Arch otolaryngol hed neck surg. 138 (10) 942-949
2012 Arch otolaryngol hed neck surg. 138 (10) 942-9492012 Arch otolaryngol hed neck surg. 138 (10) 942-949
2012 Arch otolaryngol hed neck surg. 138 (10) 942-949Helen Cox
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
Pete Shuster
 
SCT60103 March 2017 Assignment - Group 3
SCT60103 March 2017 Assignment - Group 3SCT60103 March 2017 Assignment - Group 3
SCT60103 March 2017 Assignment - Group 3
Yvonne Chin
 
Animal cell culture
Animal cell culture Animal cell culture
Animal cell culture
Anjalirawat415746
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Merck Life Sciences
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
MilliporeSigma
 
Organs on a chip
Organs on a chipOrgans on a chip
Organs on a chiprashmiakula
 
Enhanced stem cell therapy of Ischemic diseases
Enhanced stem cell therapy of Ischemic diseasesEnhanced stem cell therapy of Ischemic diseases
Enhanced stem cell therapy of Ischemic diseases
srinivas boddepalli
 
International Journal of Stem Cells & Research
International Journal of Stem Cells & ResearchInternational Journal of Stem Cells & Research
International Journal of Stem Cells & Research
SciRes Literature LLC. | Open Access Journals
 
Acacia Honey Accelerates Corneal Wound Healing
Acacia Honey Accelerates Corneal Wound HealingAcacia Honey Accelerates Corneal Wound Healing
Acacia Honey Accelerates Corneal Wound Healing
Bee Healthy Farms
 
Stem Cells 21 Medical Center
Stem Cells 21 Medical Center Stem Cells 21 Medical Center
Stem Cells 21 Medical Center
Paul Collier
 
Notes for Cell Culture Basic Techniques
Notes for Cell Culture Basic TechniquesNotes for Cell Culture Basic Techniques
Notes for Cell Culture Basic Techniques
improvemed
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
Rafa Zubair
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
HCS Pharma
 
Assignment on NEOPLASIA
Assignment on NEOPLASIA Assignment on NEOPLASIA
Assignment on NEOPLASIA
Tahir Ramzan
 
Practical 4 07
Practical 4 07Practical 4 07
Practical 4 07medik.cz
 
GTC Group 4 Assignment
GTC Group 4 AssignmentGTC Group 4 Assignment
GTC Group 4 Assignment
Calvin Chan
 

Similar to BIOMIMESYS® Oncology (20)

A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
 
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
Decellularized whartons jelly_from_human_umbilical_cord_as_a_novel_3_d_scaffo...
 
2012 Arch otolaryngol hed neck surg. 138 (10) 942-949
2012 Arch otolaryngol hed neck surg. 138 (10) 942-9492012 Arch otolaryngol hed neck surg. 138 (10) 942-949
2012 Arch otolaryngol hed neck surg. 138 (10) 942-949
 
Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaNeuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport Media
 
SCT60103 March 2017 Assignment - Group 3
SCT60103 March 2017 Assignment - Group 3SCT60103 March 2017 Assignment - Group 3
SCT60103 March 2017 Assignment - Group 3
 
Animal cell culture
Animal cell culture Animal cell culture
Animal cell culture
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
 
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
Achieving High Yields in Scalable Xeno Free Culture Formats with Mesenchymal ...
 
Organs on a chip
Organs on a chipOrgans on a chip
Organs on a chip
 
Enhanced stem cell therapy of Ischemic diseases
Enhanced stem cell therapy of Ischemic diseasesEnhanced stem cell therapy of Ischemic diseases
Enhanced stem cell therapy of Ischemic diseases
 
International Journal of Stem Cells & Research
International Journal of Stem Cells & ResearchInternational Journal of Stem Cells & Research
International Journal of Stem Cells & Research
 
CliniMACS newsletter 2011
CliniMACS newsletter 2011CliniMACS newsletter 2011
CliniMACS newsletter 2011
 
Acacia Honey Accelerates Corneal Wound Healing
Acacia Honey Accelerates Corneal Wound HealingAcacia Honey Accelerates Corneal Wound Healing
Acacia Honey Accelerates Corneal Wound Healing
 
Stem Cells 21 Medical Center
Stem Cells 21 Medical Center Stem Cells 21 Medical Center
Stem Cells 21 Medical Center
 
Notes for Cell Culture Basic Techniques
Notes for Cell Culture Basic TechniquesNotes for Cell Culture Basic Techniques
Notes for Cell Culture Basic Techniques
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
 
Assignment on NEOPLASIA
Assignment on NEOPLASIA Assignment on NEOPLASIA
Assignment on NEOPLASIA
 
Practical 4 07
Practical 4 07Practical 4 07
Practical 4 07
 
GTC Group 4 Assignment
GTC Group 4 AssignmentGTC Group 4 Assignment
GTC Group 4 Assignment
 

More from HCS Pharma

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
HCS Pharma
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...
HCS Pharma
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
HCS Pharma
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS Pharma
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCS Pharma
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
HCS Pharma
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
HCS Pharma
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
HCS Pharma
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma
 
3D innovative hiPSC-based models including the microenvironment for phenotyp...
3D innovative hiPSC-based models including the  microenvironment for phenotyp...3D innovative hiPSC-based models including the  microenvironment for phenotyp...
3D innovative hiPSC-based models including the microenvironment for phenotyp...
HCS Pharma
 
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cellsNeurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
HCS Pharma
 
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell cultureBIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
HCS Pharma
 
HCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018HCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018
HCS Pharma
 
Présentation de HCS Pharma dans la gazette du laboratoire - 2017
Présentation de HCS Pharma dans la gazette du laboratoire - 2017Présentation de HCS Pharma dans la gazette du laboratoire - 2017
Présentation de HCS Pharma dans la gazette du laboratoire - 2017
HCS Pharma
 
Urine sample-derived human induced pluripotent stem cells as a model to study...
Urine sample-derived human induced pluripotent stem cells as a model to study...Urine sample-derived human induced pluripotent stem cells as a model to study...
Urine sample-derived human induced pluripotent stem cells as a model to study...
HCS Pharma
 
3D culture in phenotypic screening : advantages, process changes and new tech...
3D culture in phenotypic screening : advantages, process changes and new tech...3D culture in phenotypic screening : advantages, process changes and new tech...
3D culture in phenotypic screening : advantages, process changes and new tech...
HCS Pharma
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
HCS Pharma
 
Augmented and Virtual Reality for the future of laboratories
Augmented and Virtual Reality for the future of laboratoriesAugmented and Virtual Reality for the future of laboratories
Augmented and Virtual Reality for the future of laboratories
HCS Pharma
 

More from HCS Pharma (18)

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
 
3D innovative hiPSC-based models including the microenvironment for phenotyp...
3D innovative hiPSC-based models including the  microenvironment for phenotyp...3D innovative hiPSC-based models including the  microenvironment for phenotyp...
3D innovative hiPSC-based models including the microenvironment for phenotyp...
 
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cellsNeurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
Neurotoxicity assessment: Comparison between SH-SY5Y and iPSC-derived cells
 
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell cultureBIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
BIOMIMESYS® Biofunctionalized hydroscaffold for 3D cell culture
 
HCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018HCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018
 
Présentation de HCS Pharma dans la gazette du laboratoire - 2017
Présentation de HCS Pharma dans la gazette du laboratoire - 2017Présentation de HCS Pharma dans la gazette du laboratoire - 2017
Présentation de HCS Pharma dans la gazette du laboratoire - 2017
 
Urine sample-derived human induced pluripotent stem cells as a model to study...
Urine sample-derived human induced pluripotent stem cells as a model to study...Urine sample-derived human induced pluripotent stem cells as a model to study...
Urine sample-derived human induced pluripotent stem cells as a model to study...
 
3D culture in phenotypic screening : advantages, process changes and new tech...
3D culture in phenotypic screening : advantages, process changes and new tech...3D culture in phenotypic screening : advantages, process changes and new tech...
3D culture in phenotypic screening : advantages, process changes and new tech...
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
 
Augmented and Virtual Reality for the future of laboratories
Augmented and Virtual Reality for the future of laboratoriesAugmented and Virtual Reality for the future of laboratories
Augmented and Virtual Reality for the future of laboratories
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

BIOMIMESYS® Oncology

  • 1. HCS Pharma – Siège de Lille Biocentre Fleming Bat A 250 rue Salvador Allende 59120 LOOS BIOMIMESYS® is a registered trademark of HCS Pharma +33 769 999 137 www.biomimesys.com hello@biomimesys.com Innovative Hydroscaffolds™ for 3D Cell Culture to better mimic the tissue microenvironment and provide more predictive tools for drug development and metabolic studies Other BIOMIMESYS® products available PRODUCT BIOMIMESYS® Oncology is a new generation of mimetic Hydroscaffolds™ for 3D cell culture. Available in a ready-to-use format, it enables the culture of cells under physiological conditions that are representative of the microenvironment found in whole tissues. The highly porous structure of BIOMIMESYS® allows cells to diffuse into the 3D matrix, where they can fix and begin to develop. The structure and conformation of cells cultured in BIOMIMESYS®, such as cancer cells that spontaneously form spheroids, strongly resemble the structures formed in vivo. Also, the functionality of the BIOMIMESYS® matrix is proved by the expression of genes and proteins at levels that are again more similar to those found in vivo. Cells cultured in BIOMIMESYS® give results that are more physiological than those grown in 2D culture and are closer to those obtained in vivo. Figure 1: SEM picture
  • 2. HCS Pharma – Siège de Lille Biocentre Fleming Bat A 250 rue Salvador Allende 59120 LOOS BIOMIMESYS® is a registered trademark of HCS Pharma +33 769 999 137 www.biomimesys.com hello@biomimesys.com Hyaluronic acid (HA) being a major component of the cell’s extracellular matrix (ECM), BIOMIMESYS® Hydroscaffolds™ for 3D cell culture is an ideal study model because it is:  Highly porous for the simple extraction of RNA and proteins  Biodegradable for easy cell retrieval  Transparent for direct visualization of cells  Representative of the cell microenvironment in terms of cell-cell interactions, cell-matrix interactions and the expression of proteins and genes  BIOMIMESYS® Oncology is made of HYALURONIC ACID (HA), a glycosaminoglycan. Hyaluronic acid is a major component of the extracellular matrix (ECM), and it plays an IMPORTANT ROLE in connective tissue.  The HA-based Hydroscaffolds™ are formed by crosslinking HA and type I collagen with ADH to form reticulated chains.  High molecular weight Hyaluronic acid + type I collagen.  BIODEGRADABLE product.  PHYSICOCHEMICAL FEATURES o Porosity: 150-200um o Rheology: Young’s modulus: E= 1 kPa +/-Swelling ratio = 75 ± 10g/g READY-TO-USE BIOMIMESYS® Hydroscaffolds™ technology is EASY to handle handling & READY-TO-USE. Upon receiving the vacuum sealed 96-well plate open it (under a hood) and add the cells directly on top of the matrix. Changing the culture medium is easy as well. To remove medium, simply draw the medium with a pipette between the matrix and the edge of the well. To refresh the medium, place fresh medium onto the surface of the matrix. 96-well plate format 10-40µl of cell suspension dropped on the surface of BIOMIMESYS® Culture medium is gently added on the side of the well to obtain qs. 200µl
  • 3. HCS Pharma – Siège de Lille Biocentre Fleming Bat A 250 rue Salvador Allende 59120 LOOS BIOMIMESYS® is a registered trademark of HCS Pharma +33 769 999 137 www.biomimesys.com hello@biomimesys.com COMPATIBLE TECHNOLOGIES BIOMIMESYS® Hydroscaffolds™ has many properties (translucent, porous, and biodegradable) that make it ideal for use with numerous downstream applications. The growing cells are easily retrieved from the matrix by a gentle and rapid procedure, this means that cells cultured in BIOMIMESYS® may be analyzed using all technologies as shown below. TRANSPARENT POROUS BIODEGRADABLE SOLID Microscopy PCRs Flow cytometry Histology Plate Reader (OD, fluorescence, luminescence Western-Blot ELISA SUCESSFULLY TESTED CELLS Cancer Cells Lines & Primary Tumors Human brain metastasis SA87 Human breast adenocarcinoma MCF-7 Human breast carcinoma CAL-51 Human cervix adenocarcinoma HeLa Human colorectal adenocarcinoma DLD-1, HT29, Caco-2 Human glioblastoma CB109 / CB74 / CB191 Human liver hepatocellular carcinoma HepG2 Human liver hepatoma PLC / PRF-5 Human lung carcinoma NCI-H460 Human osteosarcoma SaOs Human ovarian carcinoma IGROV-1 Human pancreas carcinoma PANC-1 Human prostate cancer PC3 RELATED PUBLICATIONS  “DIRECT EFFECT OF BEVACIZUMAB ON GLIOBLASTOMA CELL LINES IN VITRO“. SIMON T., COQUEREL B., ET AL. (2014) NEUROMOLECULAR MED.; 16(4):752-71  “SURVIVAL OF CORD BLOOD HAEMATOPOIETIC STEM CELLS IN A HYALURONAN HYDROGEL FOR EX VIVO BIOMIMICRY”. DEMANGE E., KASSIM Y., ET AL. (2012) J TISSUE ENG REGEN MED 7(11):901-10  “ELASTIN-DERIVED PEPTIDES: MATRIKINES CRITICAL FOR GLIOBLASTOMA CELL AGGRESSIVENESS IN A 3-D SYSTEM”. COQUEREL B., POYER F., ET AL. (2009). GLIA 57(16): 1716-26.  “COLLAGENS, STROMAL CELL-DERIVED FACTOR-1ALPHA AND BASIC FIBROBLAST GROWTH FACTOR INCREASE CANCER CELL INVASIVENESS IN A HYALURONAN HYDROGEL”. DAVID L., DULONG V., ET AL. (2008). CELL PROLIF 41(2): 348-64
  • 4. HCS Pharma – Siège de Lille Biocentre Fleming Bat A 250 rue Salvador Allende 59120 LOOS BIOMIMESYS® is a registered trademark of HCS Pharma +33 769 999 137 www.biomimesys.com hello@biomimesys.com  “HYALURONAN HYDROGEL: AN APPROPRIATE THREE-DIMENSIONAL MODEL FOR EVALUATION OF ANTICANCER DRUG SENSITIVITY.” DAVID L., DULONG V., ET AL. (2008). ACTA BIOMATER 4(2): 256-63  “RETICULATED HYALURONAN HYDROGELS: A MODEL FOR EXAMINING CANCER CELL INVASION IN 3D.” DAVID L., DULONG V., ET AL. (2004). MATRIX BIOL 23(3): 183-93 PRICING BIOMIMESYS® hydroscaffold is sold for RESEARCH USE ONLY. 96-WELL PLATE **price per plate** Quantity of 96-well plates 1 ≥ 10 ≥ 100 ≥ 1000 BIO_ONC_96_96_transp (96 well plate with 96 Hydroscaffolds™) BIO_ONC_96_24_transp (96 well plate with 24 Hydroscaffolds™) Quantity of 96-well *BLACK* plates 1 ≥ 10 ≥ 100 ≥ 1000 BIO_ONC_96_96_black (96 well plate with 96 Hydroscaffolds™) BIO_ONC_96_24_black (96 well plate with 24 Hydroscaffolds™) BIO_ONC_384_384_black (384 well plate with 384 Hydroscaffolds™) Contact Information HCS Pharma hello@biomimesys.com http://www.biomimesys.com